Clinical trial
Personalized Hemodynamic and Metabolic Signatures of Revascularization Response in Moyamoya Disease
NCT06634004 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Personalized Hemodynamic and Metabolic Signatures of Revascularization Response in Moyamoya Disease
- Lead sponsor
- Vanderbilt University Medical Center
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- September 11, 2023
- Completion date
- September 11, 2030
- Enrollment
- 100 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.